APA (7th ed.) Citation

FX, P., LJ, A., HM, H., J, D., & J, R. (2006). Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA, 295(7), 761. https://doi.org/10.1001/jama.295.7.761

Chicago Style (17th ed.) Citation

FX, Pi-Sunyer, Aronne LJ, Heshmati HM, Devin J, and Rosenstock J. "Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients: RIO-North America: A Randomized Controlled Trial." JAMA 295, no. 7 (2006): 761. https://doi.org/10.1001/jama.295.7.761.

MLA (9th ed.) Citation

FX, Pi-Sunyer, et al. "Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients: RIO-North America: A Randomized Controlled Trial." JAMA, vol. 295, no. 7, 2006, p. 761, https://doi.org/10.1001/jama.295.7.761.